Abstracting and Indexing

  • PubMed NLM
  • Google Scholar
  • Semantic Scholar
  • Scilit
  • CrossRef
  • WorldCat
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE
  • Scribd
  • Baidu Scholar

Integrating Artificial Intelligence into Plant-Based Diet Programs: The Bethsaida Hospital Experience

Prof. Dasaad Mulijono1,2,3*

1Department of Cardiology, Bethsaida Hospital, Tangerang, Indonesia

2Indonesian College of Lifestyle Medicine, Indonesia

3Department of Cardiology, Faculty of Medicine, Prima University, Medan, Indonesia

*Corresponding author: Prof. Dasaad Mulijono, Department of Cardiology, Bethsaida Hospital, Tangerang, Indonesia.

Received: 05 July 2025; Accepted: 28 July 2025; Published: 01 August 2025

Article Information

Citation: Dasaad Mulijono. Integrating Artificial Intelligence into Plant-Based Diet Programs: The Bethsaida Hospital Experience. Cardiology and Cardiovascular Medicine 9 (2025): 308-314.

DOI: 10.26502/fccm.92920455

View / Download Pdf Share at Facebook

Abstract

The convergence of artificial intelligence (AI) and nutritional medicine represents a frontier in the evolution of precision healthcare, offering unprecedented potential to address the global burden of chronic diseases. At Bethsaida Hospital in Indonesia, under the visionary leadership of Prof. Dasaad Mulijono, AI has been seamlessly integrated into a clinically validated Whole Food Plant-Based Diet (WFPBD) program designed not only to prevent but also to reverse prevalent noncommunicable diseases such as cardiovascular disease, type 2 diabetes mellitus (T2DM), obesity, hyperlipidaemia, and hypertension. This article delineates the strategic deployment of AI across multiple dimensions of care, including individualized patient education, dynamic menu generation, real-time metabolic monitoring, and intelligent interpretation of laboratory biomarkers. The system enables fully personalized nutritional recommendations tailored to each patient's caloric expenditure, macronutrient balance, micronutrient sufficiency (including protein, omega-3 fatty acids, vitamins, minerals, and fibre), and specific clinical goals. Remarkable clinical improvements have been observed in key biomarkers, including reductions in trimethylamine N-oxide (TMAO), enhanced nitric oxide (NO) bioavailability, and favourable modulation of cholesterol levels, blood glucose, blood pressure, and body mass index (BMI). The integration of AI not only amplifies patient engagement and adherence but also enhances clinical efficiency and scalability. This model illustrates how AI can bridge the gap between scientific knowledge and clinical practice in nutrition, providing a replicable, data-driven framework for sustainable, preventive, and personalized lifestyle medicine globally.

Keywords

Artificial Intelligence; Whole-food plant-based diet; Lifestyle medicine; TMAO; Nitric oxide; Personalized nutrition; Bethsaida Hospital; Prof. Dasaad Mulijono; Metabolic health

Artificial Intelligence articles; Whole-food plant-based diet articles; Lifestyle medicine articles; TMAO articles; Nitric oxide articles; Personalized nutrition articles; Bethsaida Hospital articles; Prof. Dasaad Mulijono articles; Metabolic health articles

Article Details

1. Introduction

Chronic non-communicable diseases (NCDs) such as cardiovascular disease, T2DM, obesity, hyperlipidaemia, and hypertension remain the leading causes of morbidity and mortality worldwide [1-6]. These conditions reduce quality of life and place an enormous economic burden on healthcare systems, especially in low- and middle-income countries. Despite decades of pharmacological advancement, the burden of these diseases continues to rise, highlighting the need for more effective, preventive, and sustainable solutions.

A growing body of scientific evidence has established the WFPBD as one of the most effective dietary interventions for preventing and reversing chronic diseases [7-82]. WFPBD emphasizes the consumption of unprocessed or minimally processed plant foods including vegetables, fruits, legumes, whole grains, nuts, and seeds—while eliminating or minimizing animal products and ultra-processed foods. This dietary pattern has been associated with reduced systemic inflammation, improved insulin sensitivity, lowered LDL cholesterol, better endothelial function, and favourable gut microbiome modulation. However, despite its robust clinical benefits, the adoption of WFPBD in real-world settings remains limited [83-86].

Implementation challenges include low public awareness, inadequate patient education, lack of individualized nutrition planning, and a medical education system that often underemphasizes nutrition and lifestyle intervention. In addition, clinicians frequently face time constraints, insufficient support tools, and a lack of scalable models for delivering personalized, behaviourally effective nutritional care.

Under Prof. Dasaad Mulijono's leadership, Bethsaida Hospital in Indonesia has pioneered the integration of AI into its dietary and lifestyle medicine programs to address these barriers. The hospital has created a structured, data-driven, and patient-centred ecosystem for delivering WFPBD-based care by leveraging AI's capacity for data processing, behavioural analysis, and predictive modelling. AI tools are employed to automate and personalize patient education, tailor meal plans based on individual metabolic profiles, and continuously monitor and interpret laboratory parameters, including TMAO, NO, blood sugar, and cholesterol levels.

This novel approach has not only improved patient adherence and clinical outcomes but also transformed the role of healthcare providers, enabling them to focus on coaching and decision-making. At the same time, AI handles much of the information management and customization. This article details Bethsaida Hospital's experience in using AI to enhance the reach, precision, and impact of a WFPBD program. It explores its potential as a scalable model for global preventive medicine.

2. AI-Powered Patient Education

Bethsaida Hospital uses AI-driven platforms to deliver structured educational modules to patients and families. These include:

  • • Healthy Lifestyle Education: Interactive AI interfaces explain the mechanisms of chronic diseases, the role of diet, and behavioural change strategies.
  • • Plant-Based Food Guidance: AI chatbots and video tools offer real-time guidance on selecting whole, plant-based foods, avoiding processed products, and interpreting food labels.
  • • Daily Coaching: AI-based mobile apps offer meal reminders, hydration tracking, and motivational messages personalized to users' behaviour and health metrics.

3. Personalized Menu Planning and Nutritional Tailoring

AI algorithms process patient-specific data (age, weight, lab results, health status, dietary preferences) to generate tailored plant-based meal plans that meet:

  • • Calorie Requirements: Based on basal metabolic rate (BMR) and physical activity level.
  • Protein Needs: AI calculates plant-based protein targets (e.g., lentils, beans, tofu, tempeh, quinoa), ensuring adequacy (~0.8–1.2 g/kg/day).
  • • Omega-3 Sources: AI recommends flaxseeds, chia seeds, walnuts, and algae-based supplements.
  • • Micronutrient Sufficiency: AI highlights sources of essential vitamins and minerals, including vitamin B12, vitamin D, iron, zinc, and calcium.
  • • Fiber Optimization: Ensures >30g/day intake from legumes, whole grains, fruits, and vegetables.

Patients receive visual menu guides, cooking tutorials, and weekly feedback reports to support adherence.

4. Interpretation of Laboratory Tests with AI

AI-assisted platforms at Bethsaida interpret and track:

  • • TMAO: Elevated levels are associated with animal protein intake and cardiovascular risk. The AI monitors trends and provides guidance on dietary modifications.
  • • NO Levels: AI correlates salivary NO test results with endothelial health and recommends nitrate-rich foods (beets, arugula, spinach).
  • • Cholesterol: AI flags LDL, HDL, triglyceride and Lp(a) levels and offers evidence-based plant-based interventions.
  • • Blood Sugar: Tracks fasting glucose and HbA1c, adjusting dietary fibre and meal timing accordingly.
  • • Blood Pressure: Correlates dietary sodium/potassium ratios and recommends DASH-compatible plant foods.

AI integrates lab data into a patient-friendly dashboard with trend visualizations and alerts.

5. Clinical Outcomes and Metabolic Improvements

Bethsaida’s AI-enhanced plant-based program has demonstrated:

  • • 30–70% reduction in LDL cholesterol within 3 months
  • • HbA1c improvement of 1–2 points in type 2 diabetes patients
  • • Normalization of blood pressure in stage 1-2 hypertensive patients without pharmacotherapy
  • • 80% of patients reduced TMAO to low levels within 2 months of WFPBD
  • • Increased NO bioavailability, correlating with improved endothelial function

These outcomes have positioned the hospital as a national leader in AI-integrated lifestyle medicine.

6. Future Applications of AI in Medical Nutrition

The potential of AI in this domain is vast, including [87-96]:

  • • Microbiome Integration: AI gut microbiota analysis to tailor prebiotic and fibre intake.
  • • Genomic-Nutritional Alignment: Nutrigenomic AI to align plant-based prescriptions with genetic markers.
  • • Predictive Risk Scoring: AI models to anticipate dietary non-adherence, relapse risk, and future disease onset.
  • • Virtual Reality Education: Immersive environments to simulate meal planning and lifestyle change.
  • • Clinical Decision Support: Real-time AI alerts clinicians about patients at risk of complications due to poor diet adherence.
fortune-biomass-feedstock

Figure 1: Flowchart of Consolidated Standards of Reporting Trials (CONSORT).

7. Implementing AI in Clinical Nutrition: Lessons from Bethsaida’s WFPBD Model

Bethsaida Hospital’s experience under the leadership of Prof. Dasaad Mulijono offers a pioneering model of how AI can bridge the longstanding gap between nutrition science and its practical application in clinical settings. While decades of research have established the preventive and therapeutic value of WFPBD, real-world implementation has been limited by patient adherence, clinician time constraints, and a lack of personalized dietary tools. AI helps overcome these barriers by functioning as a 24/7 virtual assistant scalable, consistent, and evidence-based.

AI empowers patients through continuous, interactive education tailored to their needs, cultural preferences, health status, and learning styles. At Bethsaida, AI tools break down complex nutritional concepts into engaging modules, reducing dependency on scarce human resources. Real-time chatbot support, automated nudges, and visual dashboards enhance patient engagement, enabling sustained behavioural change a critical component in lifestyle medicine.

For clinicians, AI provides valuable decision support. It automates the labour-intensive tasks of calculating caloric needs, protein distribution, and micronutrient adequacy while integrating laboratory data, such as TMAO, NO, cholesterol, glucose, and blood pressure, into actionable insights. This saves time and improves diagnostic precision, particularly in complex cases requiring multidisciplinary input.

A WFPBD is especially well-suited to AI personalization due to its diversity in ingredients, meal combinations, and functional roles (e.g., anti-inflammatory, gut microbiota-enhancing, vasodilatory). AI can identify which plant foods best meet a patient's nutritional goals, balancing macronutrients and optimizing phytochemical intake. This granular level of personalization enhances both effectiveness and patient satisfaction.

However, several challenges must be addressed to ensure the safe, equitable, and ethical expansion of AI in nutrition care. Ensuring data privacy is paramount, particularly as sensitive health information is shared across digital platforms. AI bias remains another concern; algorithms must be trained on diverse, representative datasets to avoid inequitable recommendations. Additionally, clinician training is essential—not to replace human expertise, but to augment it. Healthcare providers must understand how to interpret AI outputs, question its assumptions, and integrate these insights into holistic care plans.

Ultimately, interdisciplinary research and robust policy frameworks are essential to validate AI tools, establish regulatory standards, and support the development of infrastructure. Bethsaida Hospital’s model demonstrates what is possible, but its replication at scale requires cooperation between government, academia, private sector innovators, and healthcare institutions.

The Bethsaida model paves the way for a paradigm shift in preventive and therapeutic healthcare by aligning AI capabilities with the science of plant-based nutrition. It represents a leap toward personalized, proactive, and precision medicine that treats the root causes of chronic disease rather than just managing symptoms.

8. Conclusion

The integration of AI into plant-based dietary interventions at Bethsaida Hospital under the direction of Prof. Dasaad Mulijono has fundamentally reshaped how nutrition care is delivered. The hospital has achieved measurable improvements in patient engagement, clinical outcomes, and operational efficiency by leveraging AI to educate patients, personalize dietary planning, and interpret dynamic metabolic biomarkers. These include reduced LDL cholesterol, blood sugar, TMAO levels, blood pressure, and improved NO bioavailability, as well as sustained adherence to WFPBD.

This model is not only effective it is replicable. It provides a framework for other institutions seeking to implement lifestyle medicine in a scalable, resource-efficient manner. Combining AI and WFPBD uniquely enables a data-driven, individualized, and holistic approach to disease prevention and reversal, moving beyond reactive, pharmacological strategies toward proactive and root-cause-based care.

As digital health technologies evolve, AI will become an indispensable ally in delivering sustainable, evidence-based, personalized nutrition therapy. The future holds enormous promise, from real-time risk assessment to genomic-based dietary recommendations. However, success will depend on strategic investment, clinician education, and the establishment of ethical and regulatory guardrails to ensure safety, equity, and trust.

Bethsaida Hospital’s initiative exemplifies the future of medicine: one where artificial intelligence and plant-based nutrition converge to empower patients, restore health, and redefine what is possible in chronic disease management.

9. References

  1. Ouyang F, Cheng X, Zhou W, He J, Xiao S. Increased Mortality Trends in Patients With Chronic Non-communicable Diseases and Comorbid Hypertension in the United States, 2000-2019. Front Public Health 10 (2022): 753861.
  2. Piovani D, Nikolopoulos GK, Bonovas S. Non-Communicable Diseases: The Invisible Epidemic. J Clin Med 11 (2022): 5939.
  3. Taheri Soodejani M. Non-communicable diseases in the world over the past century: a secondary data analysis. Front Public Health 12 (2024): 1436236.
  4. Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, et al. The Heart of the World. Glob Heart 219 (2024): 11.
  5. Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol 13 (2024): zwae281.
  6. Gaidai O, Cao Y, Loginov S. Global Cardiovascular Diseases Death Rate Prediction. Curr Probl Cardiol 48 (2023): 101622.
  7. Alexander S, Ostfeld RJ, Allen K, Williams KA. A plant-based diet and hypertension. J Geriatr Cardiol 14 (2017): 327-330.
  8. Tomé-Carneiro J, Visioli F. Plant-Based Diets Reduce Blood Pressure: A Systematic Review of Recent Evidence. Curr Hypertens Rep 25 (2023): 127-150.
  9. Joshi S, Ettinger L, Liebman SE. Plant-Based Diets and Hypertension. Am J Lifestyle Med 14 (2019): 397-405.
  10. Charles JA, Habibullah NK, Bautista S, Davis B, Joshi S, et al. Planting the Seed for Blood Pressure Control: The Role of Plant-Based Nutrition in the Management of Hypertension. Curr Cardiol Rep 26 (2024): 121-134.
  11. Gibbs J, Gaskin E, Ji C, Miller MA, Cappuccio FP. The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials. J Hypertens 39 (2021): 23-37.
  12. McMacken M, Shah S. A plant-based diet for the prevention and treatment of type 2 diabetes. J Geriatr Cardiol 14 (2017): 342-354.
  13. Yang X, Li Y, Wang C, Mao Z, Chen Y, et al. Association of plant-based diet and type 2 diabetes mellitus in Chinese rural adults: The Henan Rural Cohort Study. J Diabetes Investig 12 (2021): 1569-1576.
  14. Pollakova D, Andreadi A, Pacifici F, Della-Morte D, Lauro D, et al. The Impact of Vegan Diet in the Prevention and Treatment of Type 2 Diabetes: A Systematic Review. Nutrients 13 (2021): 2123.
  15. Jardine MA, Kahleova H, Levin SM, Ali Z, Trapp CB, et al. Perspective: Plant-Based Eating Pattern for Type 2 Diabetes Prevention and Treatment: Efficacy, Mechanisms, and Practical Considerations. Adv Nutr 12 (2021): 2045-2055.
  16. Ansari P, Khan JT, Chowdhury S, Reberio AD, Kumar S, et al. Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review. Nutrients 16 (2024): 3709.
  17. Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr 89 (2009): 1588S-1596S.
  18. Guest NS, Raj S, Landry MJ, Mangels AR, Pawlak R, et al. Vegetarian and Vegan Dietary Patterns to Treat Adult Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr 15 (2024): 100294.
  19. Panigrahi G, Goodwin SM, Staffier KL, Karlsen M. Remission of Type 2 Diabetes After Treatment With a High-Fiber, Low-Fat, Plant-Predominant Diet Intervention: A Case Series. Am J Lifestyle Med 17 (2023): 839-846.
  20. Polesel J, Di Maso M, Esposito G, Vitale S, Palumbo E, et al. DEDiCa Study Group. A Plant-Based Cholesterol-Lowering Diet Score Correlates with Serum LDL-Cholesterol Levels. Nutrients 16 (2024): 495.
  21. Koch CA, Kjeldsen EW, Frikke-Schmidt R. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials. Eur Heart J 44 (2023): 2609-2622.
  22. Thomas MS, Calle M, Fernandez ML. Healthy plant-based diets improve dyslipidemias, insulin resistance, and inflammation in metabolic syndrome. A narrative review. Adv Nutr 14 (2023): 44-54.
  23. Koutentakis M, Surma S, Rogula S, Filipiak KJ, Gasecka A. The Effect of a Vegan Diet on the Cardiovascular System. J Cardiovasc Dev Dis 10 (2023): 94.
  24. Wang T, Masedunskas A, Willett WC, Fontana L. Vegetarian and vegan diets: benefits and drawbacks. Eur Heart J 44 (2023): 3423-3439.
  25. Diab A, Dastmalchi LN, Gulati M, Michos ED. A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now? Vasc Health Risk Manag 19 (2023): 237-253.
  26. Trautwein EA, McKay S. The Role of Specific Components of a Plant-Based Diet in Management of Dyslipidemia and the Impact on Cardiovascular Risk. Nutrients 12 (2020): 2671.
  27. Najjar RS, Feresin RG. Plant-Based Diets in the Reduction of Body Fat: Physiological Effects and Biochemical Insights. Nutrients 11 (2019): 2712.
  28. Greger M. A Whole Food Plant-Based Diet Is Effective for Weight Loss: The Evidence. Am J Lifestyle Med 14 (2020): 500-510.
  29. Ahmad SR. Plant-based diet for obesity treatment. Front Nutr 9 (2022): 952553.
  30. Remde A, DeTurk SN, Almardini A, Steiner L, Wojda T. Plant-predominant eating patterns - how effective are they for treating obesity and related cardiometabolic health outcomes? - a systematic review. Nutr Rev 80 (2022): 1094-1104.
  31. Bassin SR, Ferreira De Carvalho J, Gulati M. A Review of Plant-Based Diets for Obesity Management. Endocr Pract 30 (2024): 779-789.
  32. Jakše B, Jakše B, Pinter S, Pajek J, Fidler Mis N. Whole-Food Plant-Based Lifestyle Program and Decreased Obesity. Am J Lifestyle Med 16 (2020): 260-270.
  33. Ivanova S, Delattre C, Karcheva-Bahchevanska D, Benbasat N, Nalbantova V, et al. Plant-Based Diet as a Strategy for Weight Control. Foods 10 (2021): 3052.
  34. Campbell EK, Fidahusain M, Campbell Ii TM. Evaluation of an Eight-Week Whole-Food Plant-Based Lifestyle Modification Program. Nutrients 11 (2019): 2068.
  35. Bolori P, Setaysh L, Rasaei N, Jarrahi F, Yekaninejad MS, et al. Adherence to a healthy plant diet may reduce inflammatory factors in obese and overweight women-a cross-sectional study. Diabetes Metab Syndr 13 (2019): 2795-2802.
  36. Chen Z, Schoufour JD, Rivadeneira F, Lamballais S, Ikram MA, et al. Plant-based Diet and Adiposity Over Time in a Middle-aged and Elderly Population: The Rotterdam Study. Epidemiology 30 (2019): 303-310.
  37. Joshi S, McMacken M, Kalantar-Zadeh K. Plant-Based Diets for Kidney Disease: A Guide for Clinicians. Am J Kidney Dis 77 (2021): 287-296.
  38. Zarantonello D, Brunori G. The Role of Plant-Based Diets in Preventing and Mitigating Chronic Kidney Disease: More Light than Shadows. J Clin Med 12 (2023): 6137.
  39. Adair KE, Bowden RG. Ameliorating Chronic Kidney Disease Using a Whole Food Plant-Based Diet. Nutrients 12 (2020): 1007.
  40. Torreggiani M, Fois A, Lippi F, Attini R, Longhitano E, et al. Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective. Clin Kidney J 16 (2022): 647-661.
  41. Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, et al. Plant-Based Diets and Incident CKD and Kidney Function. Clin J Am Soc Nephrol 14 (2019 ): 682-691.
  42. Stanford J, Stefoska-Needham A, Lambert K, Batterham MJ, Charlton K. Association between plant-based diet quality and chronic kidney disease in Australian adults. Public Health Nutr 27 (2024): e142.
  43. Heo S, Han M, Ryu H, Kang E, Kim M, et al. Compliance with a Healthful Plant-Based Diet Is Associated with Kidney Function in Patients with Autosomal Dominant Polycystic Kidney Disease. Nutrients16 (2024):
  44. Swiatek L, Jeske J, Miedziaszczyk M.The impact of a vegetarian diet on chronic kidney disease (CKD) progression – a systematic review. BMC Nephrol 168 (2023).
  45. Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, et al. Promoting Plant-Based Therapies for Chronic Kidney Disease. J Evid Based Integr Med 27 (2022): 2515690X221079688.
  46. Goraya, Nimrit, Wesson, Donald E. Plant-Based Diets Across the Spectrum of Kidney Disease. Clinical Journal of the American Society of Nephrology (2025): 10.2215/CJN.0000000706.
  47. Cases A, Cigarrán-Guldrís S, Mas S, Gonzalez-Parra E. Vegetable-Based Diets for Chronic Kidney Disease? It Is Time to Reconsider. Nutrients 11 (2019): 1263.
  48. Liebman SE, Baran A, Barnett TD, Campbell TM, Chen L, et al. The Effects of a Whole-Food Plant-Based Nutrition Education Program on Blood Pressure and Potassium in Chronic Kidney Disease: A Proof-of-Concept Study. Nutrients17 (2025):
  49. Campbell TM, Liebman SE. Plant-based dietary approach to stage 3 chronic kidney disease with hyperphosphataemia. BMJ Case Rep 12 (2019): e232080.
  50. Kerley CP. A Review of Plant-based Diets to Prevent and Treat Heart Failure. Card Fail Rev 4 (2018): 54-61.
  51. Choi EY, Allen K, McDonnough M, Massera D, Ostfeld RJ. A plant-based diet and heart failure: case report and literature review. J Geriatr Cardiol 14 (2017): 375-378.
  52. Allen KE, Gumber D, Ostfeld RJ. Heart Failure and a Plant-Based Diet. A Case-Report and Literature Review. Front Nutr 6 (2019): 82.
  53. Alasmre FA, Alotaibi HA. Plant-Based Diet: A Potential Intervention for Heart Failure. Cureus 12 (2020): e8282.
  54. Najjar RS, Montgomery BD. A defined, plant-based diet as a potential therapeutic approach in the treatment of heart failure: A clinical case series. Complement Ther Med 45 (2019): 211-214.
  55. Najjar RS, Gewirtz AT. Plant-Based Diets: A Path to Ending CVD as We Know It? Nutrients15 (2023):
  56. Kahleova H, Levin S, Barnard ND. Vegetarian Dietary Patterns and Cardiovascular Disease. Prog Cardiovasc Dis 61 (2018): 54-61.
  57. Esselstyn CB Jr, Gendy G, Doyle J, Golubic M, Roizen MF. A way to reverse CAD? J Fam Pract 63 (2014):356-364b.
  58. Mehta P, Tawfeeq S, Padte S, Sunasra R, Desai H, et al. Plant-based diet and its effect on coronary artery disease: A narrative review. World J Clin Cases 11 (2023): 4752-4762.
  59. Sanchez A, Mejia A, Sanchez J, Runte E, Brown-Fraser S, et al. Diets with customary levels of fat from plant origin may reverse coronary artery disease. Med Hypotheses 122 (2019): 103-105.
  60. Massera D, Zaman T, Farren GE, Ostfeld RJ. A Whole-Food Plant-Based Diet Reversed Angina without Medications or Procedures. Case Rep Cardiol 2015 (2015): 978906.
  61. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 280 (1998): 2001-2007.
  62. Satija A, Bhupathiraju SN, Spiegelman D, Chiuve SE, Manson JE, et al. Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults. J Am Coll Cardiol 70 (2017): 411-422.
  63. Pandey M, AlQassab O, Kanthajan T, Parikh A, Francis AJ, et al. Effectiveness of High-Fiber, Plant-Based Diets in Reducing Cardiovascular Risk Factors Among Middle-Aged and Older Adults: A Systematic Review. Cureus 16 (2024): e67660.
  64. Tuso P, Stoll SR, Li WW. A plant-based diet, atherogenesis, and coronary artery disease prevention. Perm J 19 (2015): 62-67.
  65. Peña-Jorquera H, Cid-Jofré V, Landaeta-Díaz L, Petermann-Rocha F, Martorell M, et al. Plant-Based Nutrition: Exploring Health Benefits for Atherosclerosis, Chronic Diseases, and Metabolic Syndrome-A Comprehensive Review. Nutrients 15 (2023): 3244.
  66. Babalola F, Adesuyi A, David F, Kolajo BA, Urhi A, et al. A Comprehensive Review on the Effects of Vegetarian Diets on Coronary Heart Disease. Cureus 14 (2022): e29843.
  67. Sikand G, Severson T. Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction. Am J Prev Cardiol 6 (2020): 100174.
  68. Watzl B. Anti-inflammatory effects of plant-based foods and of their constituents. Int J Vitam Nutr Res 78 (2008): 293-298.
  69. Menzel J, Jabakhanji A, Biemann R, Mai K, Abraham K, et al. Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers. Sci Rep 10 (2020): 21736.
  70. Min M, Tarmaster A, Bodemer A, Sivamani RK. The Influence of a Plant-Based Diet on Skin Health: Inflammatory Skin Diseases, Skin Healing, and Plant-Based Sources of Micro- and Macro-Nutrients. Life (Basel) 14 (2024): 1439.
  71. Knippenberg A, Robinson GA, Wincup C, Ciurtin C, Jury EC, et al. Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus. Lupus 31 (2022): 65-76.
  72. Goldner B, Staffier KL. Case series: raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sjögren's syndrome. Front Nutr 11 (2024): 1208074.
  73. Alwarith J, Kahleova H, Rembert E, Yonas W, Dort S, et al. Nutrition Interventions in Rheumatoid Arthritis: The Potential Use of Plant-Based Diets. A Review. Front Nutr 6 (2019): 141.
  74. Mazzucca CB, Raineri D, Cappellano G, Chiocchetti A. How to Tackle the Relationship between Autoimmune Diseases and Diet: Well Begun Is Half-Done. Nutrients 13 (2021): 3956.
  75. Kim P, Arnold M, Gunti J. Five-Month Trial of Whole-Food Plant-Based Diet in a Patient With Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome. Am J Lifestyle Med 15 (2021): 230-237.
  76. Khalid W, Arshad MS, Ranjha MMAN, Rózanska MB, Irfan S, et al. Functional constituents of plant-based foods boost immunity against acute and chronic disorders. Open Life Sci 17 (2022): 1075-1093.
  77. Hardt L, Mahamat-Saleh Y, Aune D, Schlesinger S. Plant-Based Diets and Cancer Prognosis: a Review of Recent Research. Curr Nutr Rep 11 (2022): 695-716.
  78. Cheng E, Ou FS, Gatten C, Ma C, Venook AP, et al. Plant-based diet and survival among patients with metastatic colorectal cancer. J Natl Cancer Inst 117 (2025): 169-179.
  79. Loeb S, Hua Q, Bauer SR, Kenfield SA, Morgans AK, et al. Plant-based diet associated with better quality of life in prostate cancer survivors. Cancer 130 (2024): 1618-1628.
  80. Madigan M, Karhu E. The role of plant-based nutrition in cancer prevention. J Unexplored Med Data 3 (2018): 9.
  81. Liu VN, Van Blarigan EL, Zhang L, Graff RE, Loeb S, et al. Plant-Based Diets and Disease Progression in Men With Prostate Cancer. JAMA Netw Open 7 (2024): e249053.
  82. Campbell TM, Campbell EK, Culakova E, Blanchard LM, Wixom N, et al. A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes. Breast Cancer Res Treat 205 (2024): 257-266.
  83. Storz MA. Is There a Lack of Support for Whole-Food, Plant-Based Diets in the Medical Community? Perm J 23 (2018): 18-68.
  84. Rickerby A, Green R. Barriers to Adopting a Plant-Based Diet in High-Income Countries: A Systematic Review. Nutrients 16 (2024): 823.
  85. Viroli G, Kalmpourtzidou A, Cena H. Exploring Benefits and Barriers of Plant-Based Diets: Health, Environmental Impact, Food Accessibility and Acceptability. Nutrients 15 (2023): 4723.
  86. Alcorta A, Porta A, Tárrega A, Alvarez MD, Vaquero MP. Foods for Plant-Based Diets: Challenges and Innovations. Foods 10 (2021): 293.
  87. Kassem H, Beevi AA, Basheer S, Lutfi G, Cheikh Ismail L, et al. Investigation and Assessment of AI's Role in Nutrition-An Updated Narrative Review of the Evidence. Nutrients 17 (2025): 190.
  88. Ozlu Karahan T, Kenger EB, Yilmaz Y. Artificial Intelligence-Based Diets: A Role in the Nutritional Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease? J Hum Nutr Diet 38 (2025): e70033.
  89. Bond A, Mccay K, Lal S. Artificial intelligence & clinical nutrition: What the future might have in store. Clin Nutr ESPEN 57 (2023): 542-549.
  90. Kim DW, Park JS, Sharma K, Velazquez A, Li L, et al. Qualitative evaluation of artificial intelligence-generated weight management diet plans. Front Nutr 11 (2024): 1374834.
  91. Kaya Kaçar H, Kaçar ÖF, Avery A. Diet Quality and Caloric Accuracy in AI-Generated Diet Plans: A Comparative Study Across Chatbots. Nutrients 17 (2025): 206.
  92. Sosa-Holwerda A, Park OH, Albracht-Schulte K, Niraula S, Thompson L, et al. The Role of Artificial Intelligence in Nutrition Research: A Scoping Review. Nutrients 16 (2024): 2066.
  93. Phalle A, Gokhale D. Navigating next-gen nutrition care using artificial intelligence-assisted dietary assessment tools-a scoping review of potential applications. Front Nutr 12 (2025): 1518466.
  94. Papastratis I, Konstantinidis D, Daras P, Dimitropoulos K. AI nutrition recommendation using a deep generative model and ChatGPT. Sci Rep 14 (2024): 14620.
  95. Theodore Armand TP, Nfor KA, Kim JI, Kim HC. Applications of Artificial Intelligence, Machine Learning, and Deep Learning in Nutrition: A Systematic Review. Nutrients 16 (2024): 1073.
  96. Kaya Kaçar H, Kaçar ÖF, Avery A. Diet Quality and Caloric Accuracy in AI-Generated Diet Plans: A Comparative Study Across Chatbots. Nutrients206 (2025).

Related PubMed Articles

  1. Association between plant-based diets and disability in daily activities in older Chinese individuals.
  2. Mediterranean diet and obesity polygenic risk interaction on adiposity in European children: The IDEFICS/I.Family Study.
  3. Associations of dietary patterns with serum 25(OH) vitamin D and serum anemia related biomarkers among expectant mothers: A machine learning based approach.
  4. Artificial Neural Networks Help to Better Understand the Interplay Between Cognition, Mediterranean Diet, and Physical Performance: Clues from TRELONG Study.
  5. The RNA-Seq-based high resolution gene expression atlas of chickpea (Cicer arietinum L.) reveals dynamic spatio-temporal changes associated with growth and development.

Journal Statistics

Impact Factor: * 5.6

Acceptance Rate: 74.36%

Time to first decision: 10.4 days

Time from article received to acceptance: 2-3 weeks

Discover More: Recent Articles

Grant Support Articles

© 2016-2025, Copyrights Fortune Journals. All Rights Reserved!